WINDSOR, Conn., Feb. 27, 2018 -- Scapa Healthcare, a trusted strategic outsource partner of skin-friendly, turnkey solutions, unveiled its three R&D Centers of Excellence. Each Center offers full turn-key development services, extensive design and engineering expertise and state-of-the-art manufacturing technologies to help customers bring innovative products to market rapidly.
Located in Knoxville, TN, Orangeburg, NY and Ramsbury, UK, Scapa Healthcare’s R&D Centers of Excellence have proven capabilities delivering full turnkey solutions. Each Center features state-of-the-art manufacturing capabilities, R&D labs, specialized engineers, scientists and program managers to drive each program from development to manufacturing to commercialization in an efficient, controlled and expedited manner.
The programs are managed through a structured, lean and effective product lifecycle management process, ensuring that all products delivered to market are under full compliance. The Product Development team works jointly with the customer throughout the entire process; from product design and materials selection, to prototyping and user studies, and finally to product validation, manufacturing and commercialization. Beyond product development, Scapa Healthcare can assist with regulatory services including building technical files, stability studies, sterilization validation, product registration and post-market surveillance.
“We recognize that speed to market is critical in our industry, so we have made significant investments in technology, capabilities and personnel to help our customers bring products rapidly into the global healthcare market,” said Mike Muchin, VP of Product Development at Scapa Healthcare. “Seamlessly working side by side with our customers, even those with manufacturing capabilities, we ensure that their products are collaboratively developed and commercialized quickly and efficiently. By leveraging our development and manufacturing expertise, they can focus their efforts on marketing and commercialization of their products.”
Every R&D Center has a Class 7 or Class 8 cleanroom, robust quality systems and is compliant with ISO and FDA registrations for medical device manufacturing facilities.
About Scapa Healthcare
Scapa Healthcare is a global trusted strategic outsource partner of skin friendly turn-key solutions for advanced wound care, consumer wellness and medical device markets. Scapa Healthcare partners with market leaders to design, develop, manufacture and commercialize innovative skin contact solutions to meet end-user needs. Scapa Healthcare offers turn-key development services, including design and project management; coating; converting, perforation and assembly; printing and packaging; and sterilization services. For more information, visit: www.scapahealthcare.com
Media Contact
Jordan Bouclin
SVM Public Relations and Marketing Communications
[email protected]
(401)490-9700
Scapa Healthcare Contact
Beth Schivley
SHC MarCom Manager
[email protected]
860-902-8157


Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 



